Clinical Pharmacokinetics of Idarubicin
- 1 April 1993
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 24 (4), 275-288
- https://doi.org/10.2165/00003088-199324040-00002
Abstract
Idarubicin (4-demethoxy-daunorubicin) is a new commercially available anthracycline antibiotic which is more active in in vitromodels than doxorubicin, the accepted reference drug, in the treatment...Keywords
This publication has 54 references indexed in Scilit:
- Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parametersBritish Journal of Cancer, 1992
- Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia.1992
- Plasma Pharmacokinetics of Idarubicin and its 13-Hydroxymetabolite after Intravenous and Oral Administration under Fasting and Non-Fasting ConditionsActa Oncologica, 1990
- Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in cultureBiochemical Pharmacology, 1989
- Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cellsBiochemical Pharmacology, 1989
- Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patientsCancer Chemotherapy and Pharmacology, 1987
- Pharmacokinetics of idarubicin (4‐demethoxydaunorubicin; IMI‐30; NSC 256439) following intravenous and oral administration in patients with advanced cancer.British Journal of Clinical Pharmacology, 1987
- Low dose oral administration of 4-demethoxy-daunorubicin (idarubicin) in advanced cancer patientsCancer Chemotherapy and Pharmacology, 1986
- Hepatic extraction of adriamycin in patients with hepatocellular carcinomaEuropean Journal of Cancer and Clinical Oncology, 1984
- ACTIVITY AND DISTRIBUTION OF IV AND ORAL 4-DEMETHOXYDAUNORUBICIN IN MURINE EXPERIMENTAL-TUMORS1984